BG Medicine, Inc.
BG Medicine Files US Registration Statement with SEC in Support of Euronext Amsterdam IPO
Published in Law and Health Weekly, August 25th, 2007
BG Medicine, Inc. announced it has filed a registration statement on Form S-1 with the United States Securities and Exchange Commission (SEC) for a proposed Initial Public Offering (IPO) of its common stock. All of the shares to be offered will be sold by the company. The number of shares to be sold and the price range for the offering have not yet been determined. BG Medicine intends to apply for its common stock to list and trade on Euronext Amsterdam by NYSE Euronext under the symbol "BGMDX".
Cowen International Limited and Fortis will be acting as joint global coordinators and joint book-runners for the offering. Leerink Swann & Company will act as...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Aarp
Seniors Set to be Hit Hard by Illinois Budget - Americans United for Life
Kansas Abortionist Tiller's Claims Without Merit Americans United for Life Amicus Brief Says - Amyotrophic Lateral Sclerosis
New findings from Columbia University in the area of amyotrophic lateral sclerosis published - Bioengineering
AutoImmune Inc. Reports 2007 Second Quarter Financial Results - Bioengineering
Point Therapeutics Reports Second Quarter 2007 Financial Results - Biomedicine
Spectral reports second quarter results - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
